FDA’s Untitled Letter Posting Driven By ‘Significant Public Interest,’ Not Stock Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Response to congressional inquiry also notes that FDA's policy is not to make policy in untitled letters.